Visual improvement after long-term success of pancreatic transplantation by Friberg, TR et al.
-_._-_._------_ .... _---_ .... _ ... 
LETTERS TO THE JOURNAL 
Visual Improvement After Long-term 
Success of Pancreatic 
Transplantation 
Thomas R. Friberg, M.D., 
Andreas G. Tzakis, M.D., 
Patricia B. Carroll, M.D., 
and Thomas E. Starzl, M.D. 
Department of Ophthalmology, University of Pitts-
burgh School of Medicine. 
Inquiries to Thomas R. Friber8, M.D., Department of 
Ophthalmology, University 01 Pittsburgh Schoo! of 
Medicine, Eye and Ear Institute, 203 Lothrop St., PItts-
burgh, PA 15213. 
Several investigators have reported that pan-
creatic transplantation does not appear to have 
a favorable effect on diabetic retinopathy .1.2 In a 
series of 22 patients who were followed up an 
average of 24 months, Ramsey and associates2 
reported that the functional success of the 
transplantation did not prevent progression of 
diabetic retinopathy and that visual loss secon-
dary to diabetic maculopathy occurred in some 
patients. 
Fourteen patients received cadaveric pancre-
atic transplants at our institution between 
March 1983 and November 1985 after or in 
conjunction with renal transplantation. Pa-
tients were immunosuppressed with oral cyclo-
sporine and prednisone to which antilym-
phocytic globulin, the monoclonal antibody 
OKT3, and azathioprine were added as needed. 
Patients were examined at least every six 
months with visual acuity measurements, oph-
thalmoscopy, and fundus photography. Photo-
graphs were evaluated and graded by using 
conventional criteria.3 
Eight patients had functional pancreatic 
grafts and maintained euglycemia (mean total 
hemoglobin AI' 5.0 to 7.4 g/dl) for more than 
six months without diabetic medications. Of 
this group of 16 eyes, no eyes showed improve-
ment in diabetic retinopathy scores during the 
period of graft survival, five worsened, and 11 
remained stable. 
Four patients maintained functioning pancre-
atic grafts for more than 48 months. These 
patients were 31, 33, 38, and 45 years of age, 
respectively (Cases 1 through 4). All patients 
had had combined kidney and pancreatic trans-
plants except the patient in Case 2, who had a 
kidney transplant performed before pancreatic 
transplantation. All four patients had been 
treated previously with panretinallaser photo-
coagulation in each eye. In Case I, the patient 
also had had a vitrectomy in the right eye and 
macular grid treatment in the left eye. 
At study entry, one patient (Case 1) had 
visual acuity of R.E.: light perception and L.E.: 
20/50. Macular edema was noted in the left eye 
as determined by clinical examination and as 
seen on stereoscopic fundus photog.raphs. Four 
years later, the macular edema had resolved 
and visual acuity in the left eye improved to 
20/25. 
The patient in Case 2 had visual acuity of 
20/60 in both eyes with bilateral macular ede-
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rna at entry. Over the four-year period, a ~~trec­
tomy was required in each eye and addltlOnal 
panretinal photocoagulation was needed in the 
right eye. The macular edema resolved and 
visual acuity improved to 20/40 in each eye at 
48 months. 
In Case 3, the patient had visual acuity of 
R.E.: no light perception and L.E.: 20/20 before 
pancreatic and kidney transplantation. Visual 
acuity remained unchanged throughout the fol-
low-up period and the preViously treated pro-
liferative diabetic retinopathy remained stable. 
The patient in Case 4 had visual acuity of 
R.E.: 20/40 and L.E. 20/100 with diabetic mac-
ular edema in both eyes before transplantation. 
Additional panretinal photocoagulation was 
added during the course of follow-up. Visual 
acuity improved to R.E.: 20/30 and L.E.: 20/60 
at 48 months, and the macular edema in each 
eye resolved. 
Although no patient had a significant lens 
opacity before pancreatic transplantation, the 
left eye of one patient (Case 1) and both eyes of 
another patient (Case 2) developed posterior 
su bcapsular cataracts associated with long-
term prednisone treatment. Uneventful cataract 
removal and intraocular lens implantation were 
performed during the course of follow-up. 
The findings in these patients confirm the 
previous finding that pancreatic transplanta-
tion in patients with preexisting proliferative 
diabetic retinopathy does not prevent progres-
sion of the retinopathy despite euglycemia. Our 
cases, however, suggest that long-term excel-
lent visual function can be attained if the prolif-
erative disease is treated appropriately. Four of 
six seeing eyes ultimately improved two lines of 
visual acuity or better, whereas the remaining 
seeing eyes maintained stable vision. Improve-
ment of vision was not inconsequential, as it 
allowed two patients to drive their automobiles 
and return to work. 
It is difficult to ascertain precisely how the 
functioning pancreatic grafts in these patients 
affected visual outcome. We find it noteworthy, 
however, that the macular edema noted initial-
ly in these patients eventually subsided with-
out subsequent macular grid therapy. Although 
this improvement could be partially attributed 
to kidney transplantation and restoration of 
renal function, neither vision nor the maculo-
pathy improved during the .first 18 months after 
transplantation. These patu=.nts also had addi-
tional panretinal photocoagulation, but this 
type of laser treatment generally. exacerbates 
diabetic maculopathy rather than lmproves it. 
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The fetal alcohoi syndrome is characterized 
by prenatal and postnatal growth retardation, 
mild to severe mental retardation, central nerv-
ous system, cardiovascular, and skeletal anom-
alies, and characteristic facial features includ-
ing a narrow forehead, short and upturned 
nose, a long upper lip with indistinct or absent 
philtrum, and low nasal bridge.! A number of 
ocular malformations have been reported in the 
fetal alcohol syndrome including bilater~l mild 
to moderate blepharoptosis (which usually be-
comes more noticeable in adolescence), hori-
zontally shortened palpebral fissures, epican-
thus, strabismus, retinal vessel tortuosity, optic 
nerve hypoplasia, myopia, cataract, Peters' 
anomaly, and microphthalmia.! We treated a 
patient with bilateral Duane's retraction syn-
drome type III (limited abduction and adduc-
tion of involved eye~ and the fetal alcohol 
syndrome. 
An i I-year-old girl with fetal alcohol syn-
drome had characteristic facial features, growth 
retardation, and central nervous system dys-
